Gastrointestional

COLON/RECTAL

PREVENTION

  • SWOG S0820– A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage O-III Colon Cancer Phase III- Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)

NEOADJUVANT

  • NCCTG N1048– Phase II/III Randomized Study of Neoadjuvant FOLFOX Therapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil Versus Chemoradiation Comprising Fluorouracil or Capecitabine, and Radiation Therapy in Patients With Locally Advanced Rectal Cancer Undergoing Low-Anterior Resection With Total Mesorectal Excision

Adjuvant

  • Alliance A021502– Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy of Patients with Stage III Colon Cancer with Deficient DNA Mismatch Repair (ATOMIC)

Metastatic

  • SWOG S1417CD– Implementation of a Prospective Financial Impact Assessment Tool in Patients with Metastatic Colorectal Cancer